PIPELINE

MORE
JAK2 Inhibition to Treat Platinum Resistant Ovarian Cancer
Intranasal Oxytocin to Treat Heart Failure
Aprepitant to treat hypomagnesemia and skin lesions during chemotherapy
New biomarkers and targets to Identify and Treat Corticosteroid-Resistant Asthma
SULFASALAZINE AS A TREATMENT FOR SARCOIDOSIS – RESULTS OF A CLINICAL PILOT STUDY
Anti CD19/CD11c Bi-Specific Antibodies Target a Subset of B Cells to Treat Autoimmu..
Targeting CYP11A1 in the Steroidogenic Pathway For Treating Allergic Diseases
Novel PIM 1 Kinase Inhibitor that Upregulates RUNX3 for the Treatment of Allergic D..
Novel Lipid Inhibitors of TLR Effective at Reducing RSV and Influenza A Infection I..

GLOBAL C&D PROJECT PARTICIPANTS




    • Aagami
    • Bionaturis
    • Allovate
    • Cellmid
    • Amorchem
    • Crossbeta Biosciences
    • Aurigene
    • Intrommune Therapeutics
    • Kissei Pharmaceutical
    • MyeloRx
    • Genefrontier
    • Coarebiotech
    • Immune Biosolutions
    • NEOMED
    • APIM Therapeutics
    • Ulster University
    • Southern Research
    • UCL
    • Atrin Pharmaceuticals
    • LTTO
    • AVEO Pharmaceuticals
    • ULB
    • Amunix
    • University of Namur
    • iVeena
    • Valin Technologies
    • MBM Sciencebridge
    • Wiborg
    • Aronora, Inc.
    • Lipopharma
    • Aeterna Zentaris
    • cancer research technology
    • yissum
    • yeda